Psilocybin and Psychotherapy May Dramatically Reduce Alcohol Consumption
New study links psilocybin to a major decline in heavy drinking and complete cessation in nearly half of participants.
Psychogenic Nonepileptic Seizures: Exploring Unmet Needs
A specialist in functional neurological disorders calls for greater attention to little-understood condition.
Defining Mental Health Strategies for Responding to COVID-19
As the pandemic entered its second year, NYU Langone Health researchers led in outlining responses to reduce psychiatric harms.
Untangling Schizophrenia’s Ties to COVID-19 Mortality
Unsettling finding associate the mental illness with nearly three times higher risk of death.
Early Neurorehabilitation Shows Promise in Disorders of Consciousness after COVID-19
More than half of severely impaired patients demonstrate improvements in responsiveness before discharge.
NYU Langone Health: A Leader in Psychiatry
rated residency program (Doximity)
in NIH research funding (Blue Ridge)
CME, Symposia & Events
Update on Attention Deficit Hyperactivity Disorder Through the Lifespan
December 3, 2022
8:15 AM – 4:05 PM ET
This course will focus on the latest issues in Attention Deficit Hyperactivity Disorder (ADHD) throughout the lifespan – in children, adolescents, and adults. Topics to be covered include sluggish cognitive tempo; treatment of ADHD with a focus on new therapies; ADHD and substance use disorders; co-morbid conditions in ADHD; diagnosis of ADHD in adulthood; and exposure to systemic viruses and ADHD symptoms. The course will be a full-day, virtual activity with a breakout “Ask the Expert” session.Register Now
Get Practice-Changing Specialty News from the Nation’s #3 Hospital
Select your specialty areas of interest to receive our latest complex case studies, research highlights, expert perspectives, and other news.